Ultragenyx Pharmaceutical
RARE
#3224
Rank
A$5.36 B
Marketcap
$57.10
Share price
2.82%
Change (1 day)
-16.15%
Change (1 year)

P/S ratio for Ultragenyx Pharmaceutical (RARE)

P/S ratio as of April 2025 (TTM): 5.98

According to Ultragenyx Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.8. At the end of 2024 the company had a P/S ratio of 7.16.

P/S ratio history for Ultragenyx Pharmaceutical from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.16-20.85%
20239.041.15%
20228.94-45.19%
202116.3-51.73%
202033.841.86%
201923.8-44.54%
201842.9-94.32%
2017756-96.5%
2016> 1000
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.98-33.54%๐Ÿ‡บ๐Ÿ‡ธ USA
3.97-33.60%๐Ÿ‡บ๐Ÿ‡ธ USA
0.5656-90.54%๐Ÿ‡บ๐Ÿ‡ธ USA
5.93-0.88%๐Ÿ‡บ๐Ÿ‡ธ USA